Circulating oxyntomodulin-like immunoreactivity in healthy children and children with celiac disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 27, Issue 5, 1998, Pages 513-518

  Le Quellec, Alain ^a   Clapié, Marjorie ^b   Callamand, Pierre ^b   Lehmann, Michel ^b   Kervran, Alain ^b   Bataille, Dominique ^b   Rieu, Daniel ^b  

^a HÔPITAL SAINT ELOI   (France)

^b NONE

Author keywords

Celiac disease; Gastrointestinal hormones; Oxyntomodulin

Indexed keywords

FOLIC ACID; HEMOGLOBIN; OXYNTOMODULIN;

ADOLESCENT; ARTICLE; CELIAC DISEASE; CHILD; CHRONIC DIARRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROENTERITIS; GLUTEN FREE DIET; HORMONE BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; INFANT; INTESTINE BIOPSY; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FASTING; FEMALE; GLUCAGON-LIKE PEPTIDES; HUMANS; MALE; OXYNTOMODULIN; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY;

EID: 0031723943     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199811000-00003     Document Type: Article

References (41)

1. Le Quellec A, Kervran A, Blache P, Ciurana AJ, Bataille D. Oxyntomodulin-like immunoreactivity: Diurnal profile of a new potential enterogastrone. J Clin Endoc Metab 1992;74:1405-9.
2. Jarrousse C, Carles-Bonnet C, Niel H, et al. Inhibition of gastric acid secretion by oxyntomodulin and its [19-37] fragment in the conscious rat. Am J Physiol 1993;264:G816-23.
3. Schjoldager BTG, Baldissera FGA, Mortensen PE, Holst JJ, Christiansen J. Oxyntomodulin: A potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 1988;18:499-503.
4. Veyrac M, Ribard D, Daures JP, et al. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man. Scand J Gastroenterol 1989;24:1238-42.
5. Le Quellec A, Kervran A, Blache P, Ciurana AJ, Bataille D. Diurnal profile of oxyntomodulin-like immunoreactivity in duodenal ulcer patients. Scand J Gastroenterol 1993;28:816-20.
6. Lawaetz O, Blackburn AM, Bloom SR, Aritas Y, Ralphs DNL. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. Scand J Gastroenterol 1983;18:73-80.
7. Andrews NJ, Irving MH. Human gut hormone profiles in patients with short bowel syndrome. Dig Dis Sci 1992;37:729-32.
8. Besterman HS, Cook GC, Sarson DL, et al. Gut hormones in tropical malabsorption. BMJ 1979;2:1252-5.
9. Besterman HS, Bloom SR, Sarson DL, et al. Gut-hormone profile in coeliac disease. Lancet 1978:1(8068):785-8.
10. Working group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990;65:909-11.
11. Recommended dietary allowances. 9th ed. Washington DC: National Academy of Sciences. 1980:1-185.
12. Bataille D. Oxyntomodulin and its related peptides. In: Lefebvre PJ, ed. Glucagon III: Handbook of experimental pharmacology. Heidelberg: Springer 1996;123:327-40.
13. Blache P, Kervran A, Martinez J, Bataille D. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen. Anal Biochem 1988;173:151-9.
14. Blache P, Kervran A, Le-Nguyen D, et al. The glucagon-containing peptides and their fragments in the rat gastro-entero-pancreatic and central nervous system. Biomed Res 1988;9(suppl3):19-28.
15. Lucas A, Bloom SR, Aynsley-Green A. Postnatal surges in plasma gut hormones in term and preterm infants. Biol Neonate 1982;41: 63-7.
16. Lucas A, Bloom SR, Aynsley-Green A. Gut hormones and "minimal enteral feeding." Acta Paediatr Scand 1986;75:719-23.
17. Murphy MS, Brunetto AL, Pearson AD, et al. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Dig Dis Sci 1992;37:2:187-92.
18. Hernanz A, Polanco I, Codoceo R, Lama R, Vazquez C. Gastrointestinal peptide profile in children with coeliac disease. J Pediatr Gastroenterol Nutr 1987;6:341-5.
19. Beck B, Villaume C, Debry G. Clinical aspects of VIP secretion. Acta Diabetol Lat 1982;19:1-11.
20. Green DW, Gomez G, Greeley GH. Gastrointestinal peptides. Gastroenterol Clin North Am 1989;18:695-733.
21. Kumar PJ, Walker-Smith J, Milla P, Harris G, Colyer J, Halliday R. The teenage coeliac: Follow-up study of 102 patients. Arch Dis Child 1988;63:916-20.
22. Mäki M, Lähdeaho ML, Hällstöm O, Viander M, Visakorpi JK. Postpubertal gluten challenge in coeliac disease. Arch Dis Child 1989;64:1604-7.
23. Guandalini S, Ventura A, Ansaldi N, et al. Diagnosis of coeliac disease: Time for a change? Arch Dis Child 1989;64:1320-5.
24. Carson DJ, Glasgow JFT, Buchanan KD, Sloan JM. Changes in N-terminal glucagon-like immunoreactivity and insulin during short-term gluten challenge in childhood coeliac disease. Gut 1981;22:554-7.
25. Kilander AF, Stenhammar L, Lindstedt G, Lundberg PA. Determination of enteroglucagon in plasma for detection of coeliac disease in children. Clin Chem 1984;30:77-80.
26. Stenhammar L, Strömberg L, Kilander AF, Lindstedt G, Lundberg PA. Plasma enteroglucagon in the control of childhood coeliac disease. J Pediatr Gastroenterol Nutr 1985;4:325-30.
27. Kilander AF, Dotevall G, Lindstedt G, Lundberg PA. Plasma enteroglucagon related to malabsorption in coeliac disease. Gut 1984; 25:629-35.
28. Matsuyama T, Itoh H, Watanabe N, et al. Glucagon-(1-21)-peptide as an active enteroglucagon. Biomed Res 1988;9(Suppl 3):137-42.
29. Gornacz GE, Ghatei MA, Al-Mukhtar MYT, et al. Plasma enteroglucagon and CCK levels and cell proliferation in defunctioned small bowel in the rat. Dig Dis Sci 1984;29:1041-9.
30. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997;36:E77-84.
31. Beauclair F, Pansu D, Rodier G, et al. Effects of oxyntomodulin and related peptides on the hydromineral transport through rat small intestine (abstract). Regul Pept 1996;64:10. Abstract.
32. Rodier G, Magous R, Mochizuki T, et al. Effect of glicentin, oxyntomodulin and related peptides on isolated smooth muscle cells from rabbit antrum. Pflugers Arch 1997;434:729-34.
33. Kokkonen J, Similä S. Gastric function and absorption of vitamin B12 in children with coeliac disease. Eur J Pediatr 1979;132:71-5.
34. Rominger JM, Chey WY, Chang TM. Plasma secretin concentrations and gastric pH in healthy subjects and patients with digestive diseases. Dig Dis Sci 1981;26:591-7.
35. Marcello U, Deganello A, Consolaro G, Zoppi G. Gastric secretory function in coeliac disease. Eur J Pediatr 1979;130:29-34.
36. Buchan AM, Grant S, Brown JC, Freeman HJ. A quantitative study of enteric endocrine cells in coeliac sprue. J Pediatr Gastroenterol Nutr 1984;3:665-71.
37. Sjölund K, Alumets J, Berg NO, Hakanson R, Sundler F. Duodenal endocrine cells in adult coeliac disease. Gut 1989;7:547-52.
38. Andersson H, Björkman AC, Gillberg R, Kastrup W, Mobacken H, Stockbrügger R. Influence of the amount of dietary gluten on gastrointestinal morphology and function in dermatitis herpetiformis. Hum Nutr Clin Nutr 1984;38:279-85.
39. Carroccio A, Iacono G, Montalto G, et al. Immunologic and absorptive tests in coeliac disease: Can they replace intestinal biopsies? Scand J Gastroenterol 1993;28:673-6.
40. Berg NO, Borulf S, Jacobson I, Lindberg T. How to approach the child suspected of malabsorption. Acta-Paediatr Scand 1978;67: 403-11.
41. Stahlberg MR, Hietanen E, Mäki M. Mucosal biotransformation rates in the small intestine of children. Gut 1988;29:1058-63.